Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(594/week)
Manufacturing
(436/week)
Energy
(328/week)
Technology
(473/week)
Other Manufacturing
(362/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Primary biliary cholangitis
Oct 31, 2019
Pliant Therapeutics to Present Preclinical Data in Primary Sclerosing Cholangitis at The Liver Meeting 2019
Aug 12, 2019
Strategic in-licensing Related to Autoimmune Hepatitis in the US Market
Jul 10, 2019
The global primary biliary cholangitis therapeutics market at a CAGR of close to 10% during the forecast period
Jul 09, 2019
Mirum Pharmaceuticals Initiates Phase 3 Clinical Trial for Pediatric Patients with Progressive Familial Intrahepatic Cholestasis
Jun 19, 2019
Global Ursodeoxycholic Acid Market to Surpass US$ 1,075.5 Million by 2026 - Coherent Market Insights
Jun 17, 2019
Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH
Apr 15, 2019
Mirum Pharmaceuticals Presents New Data Demonstrating Durable Improvements in Clinical Outcome Measures in Patients with PFIC2 and Alagille Syndrome Treated with Maralixibat
Mar 27, 2019
Mirum Pharmaceuticals to Present Phase 2 Clinical Results of Maralixibat in Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis at the International Liver Congress
Mar 21, 2019
Mirum Pharmaceuticals Appoints Chris Peetz as Chief Executive Officer
Feb 12, 2019
Calliditas Therapeutics Granted Orphan Drug Designation by the FDA for Primary Biliary Cholangitis
Nov 12, 2018
Data released at The Liver Meeting ® 2018 Shows MRCP+ is a Promising Non-Invasive Technology for Quantitative Evaluation of Hepatobiliary Diseases
Nov 07, 2018
Mirum Pharmaceuticals Secures $120 Million in Series A Financing to Develop Phase 3-Ready Maralixibat for Rare Liver Diseases
Apr 14, 2018
NGM Bio Announces Results From Phase 2 Study Of NGM282 In NASH Patients Demonstrating Clinically Significant Improvements In Liver Histology After 12 Weeks
Apr 13, 2018
NGM Bio Announces Late-Breaking Plenary Presentation At International Liver Conference 2018 Of Detailed Results From Phase 2 Study Of NGM282 In Patients With Primary Sclerosing Cholangitis
Feb 20, 2018
DURECT Corporation to Host Key Opinion Leader Call on Treatment of Primary Sclerosing Cholangitis (PSC)
Latest News
May 3, 2024
Luna Innovations Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
May 3, 2024
Global Fuel Cell (PEMFC, PAFC, MCFC & SOFC) Market Insights & Forecasts, 2023-2024 & 2028:...
May 3, 2024
Core Scientific, Inc. Schedules First Quarter Fiscal Year 2024 Earnings Release, Conference Call and Webcast
May 3, 2024
Rising Demand for Data Storage Propels Data Center Power Market to US$37.9 Billion by 2029 - Colocation...
May 3, 2024
Flowserve to Participate in Upcoming Investor Conferences
May 3, 2024
Tennant Company Reports First Quarter 2024 Results
May 3, 2024
SemiLink Materials Secures Growth Capital to Advance U.S. Semiconductor Material Supply Chain Buildout
May 3, 2024
Tennant Company Launches International Expansion of the i-mop Family of Products
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events